The Carlat Addiction Treatment Report, Volume 9, Number 7&8, November 2021
Noah Capurso, MD
Assistant professor of psychiatry at Yale University, CT. Editor-in-chief of The Carlat Addiction Treatment Report.
Dr. Capurso has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Buprenorphine is a first line medication for the treatment of opioid use disorder yet remains vastly under-prescribed. Here, Dr. Capurso reviews the pharmacologic principles relevant to buprenorphine prescribing and lays out how to start patients on the medication both in the clinic and at home.